EBITDA: Income before interest, taxes, depreciation and amortization.
Emmaus Life Sciences, Inc. (EMMA) had EBITDA of $-0.24M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$2.82M |
|
$-1.14M |
|
$0.15M |
|
$2.67M |
|
$3.19M |
|
$-0.37M |
|
$-1.35M |
|
$-1.73M |
|
$-1.19M |
|
$-1.14M |
|
$-1.14M |
|
$-1.14M |
|
$-0.42M |
|
$-0.37M |
|
|
EBITDA |
$-0.24M |
63.87M |
|
63.87M |
|
$-0.02 |
|
$-0.02 |
|
| Balance Sheet Financials | |
$5.01M |
|
$0.14M |
|
$18.33M |
|
$23.34M |
|
$62.08M |
|
$2.26M |
|
$16.97M |
|
$79.05M |
|
$-55.70M |
|
$-55.70M |
|
$-55.70M |
|
63.87M |
|
| Cash Flow Statement Financials | |
$-2.63M |
|
$2.17M |
|
$-0.06M |
|
$1.39M |
|
$0.89M |
|
$-0.50M |
|
$0.01M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.08 |
|
-- |
|
-- |
|
-0.04 |
|
-0.55 |
|
94.68% |
|
-13.13% |
|
-13.13% |
|
-- |
|
-61.24% |
|
-40.29% |
|
$-0.46M |
|
-- |
|
-- |
|
-- |
|
0.12 |
|
0.11 |
|
1.36 |
|
66.17 |
|
2.04% |
|
2.04% |
|
-4.86% |
|
2.12% |
|
$-0.87 |
|
$-0.01 |
|
$-0.04 |
|